Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P22362
UPID:
CCL1_HUMAN
Alternative names:
Small-inducible cytokine A1; T lymphocyte-secreted protein I-309
Alternative UPACC:
P22362; B2R5G9; Q2M309
Background:
C-C motif chemokine 1, also known as Small-inducible cytokine A1 and T lymphocyte-secreted protein I-309, plays a pivotal role in immune responses. Identified by its unique ability to be chemotactic for monocytes but not neutrophils, it specifically binds to the CCR8 receptor. This specificity underscores its unique position in the chemokine family, orchestrating cellular movement and immune cell targeting.
Therapeutic significance:
Understanding the role of C-C motif chemokine 1 could open doors to potential therapeutic strategies. Its precise function in immune cell regulation and its exclusive interaction with CCR8 present intriguing possibilities for targeted therapy in immune-related disorders.